COMPLIANCE PATTERN OF PHARMACOLOGICAL REGIMENS IN HYPERTENSIVES AND/OR DYSLIPIDEMIC PATIENTS IN AMBULATORY CARE IN A SPANISH POPULATION

Author(s)

Jaime F Bobadilla, MD, Outcomes Research Manager CV1, Antoni Sicras, MD, Head of Information Systems2, Ruth Navarro, MD, Head of Medical Documentation2, Mercedes García, PhD, Outcomes Research Technician31Pfizer Spain, Madrid, Spain; 2 Badalona Servicios Asistenciales, Barcelona, Spain; 3 Euroclin Institute, Alcobendas, Madrid, Spain

OBJECTIVES: Lack of adherence is a major determinant of inadequate control of cardiovascular risk factors. The aim of this study is to evaluate the level of therapeutic compliance among patients with mild to moderate hypertension (HT) and/or dislipidemia (DL), in a primary care setting in daily medical practice, and to determine factors associated with TC. METHODS: A retrospective multicentric study was performed from a one-year (2005) registry of patients from five primary care centres in Spain. Inclusion criteria were as follows: mild to moderate HT as per JNC-VII, British Hipertensión-Society; and DL as per NCEP-ATP III. Compliance was estimated by the relationship between the amount of dispensed and prescribed pills. Demographic variables, comorbidities, clinical parameters and sanitary resources were registered. A bivariant analysis and a multiple lineal regression analysis were done to correct the model. RESULTS: Compliance was estimated from the total sample of 15,606 patients (HT: 41.7%; DL: 23.1%; HT/DL: 35.2%), in 85.9% (CI=85.4-86.4%), 81.6% (CI=81.0-82.2%) and 84.9% (CI=84.3-85.5%) respectively (p=0.000; Scheffé). Explanatory variables of a better compliance in the multivariate analysis were (beta=0.832; t=59.1; p=0.000): a) direct relationship: age, labour inactivity, drug price, and b) indirect relationship: glycemia, triglycerides, LDL and number of active principles used (p=0.000). CONCLUSION: Dyslipidemic patients show a worse compliance than hypertensive patients, and dyslipidemia worsened global compliance in hypertensive patients. Certain clinical parameters of control, the age of the patient and the drug group are related to compliance in daily medical practice.

Conference/Value in Health Info

2006-10, ISPOR Europe 2006, Copenhagen, Denmark

Value in Health, Vol. 9, No.6 (November/December 2006)

Code

PCV83

Topic

Patient-Centered Research

Topic Subcategory

Adherence, Persistence, & Compliance

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×